Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe side effects most people experience on Wegovy are real but often far milder than the stories circulating online suggest. Nausea, some digestive upset and occasional fatigue are the most commonly reported effects of semaglutide treatment, and for the majority of people they settle within the first few weeks as the body adjusts. That said, these are genuine effects worth understanding before you start, and a small number of symptoms do warrant prompt medical attention. Wegovy is a prescription-only medicine; a prescriber reviews your full health picture before recommending it, and side-effect management is part of that ongoing clinical relationship.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Ask around and you will hear vivid stories, days of nausea, barely able to eat, struggling to function. Those experiences are real for some people. But they are not the whole picture, and treating them as the default is one of the most common misunderstandings about Wegovy's side-effect profile.
Clinical trial data published in the STEP 1 study in the New England Journal of Medicine showed that gastrointestinal effects were indeed the most frequently reported category, but most were described as mild to moderate in severity, and most resolved without stopping treatment. The slow, stepped titration schedule (moving up in dose roughly every four weeks under prescriber guidance) exists precisely to reduce the shock to your digestive system. Side effects tend to cluster around dose increases, then subside. Many people find the adjustment at 0.5mg is harder than later steps.
So the myth to correct first is not that side effects happen, but that they are uniformly severe and permanent. For a meaningful proportion of people, they are manageable interruptions rather than a reason to stop.
The NHS medicines page for semaglutide lists the most common effects: nausea, vomiting, diarrhoea, constipation, stomach pain, indigestion, belching and fatigue. Headache and dizziness appear less often. Injection-site reactions (redness, itching, a small lump) are possible with any subcutaneous injection and usually settle quickly.
Nausea is by far the most reported. It tends to be worst in the first day or two after an injection, particularly after increasing the dose. Eating smaller portions, avoiding rich or fatty food around injection day, and staying well hydrated all help most people get through the adjustment window. If nausea is a pattern that concerns you, that is worth raising with your prescriber rather than quietly enduring it.
A quick habit worth building: the morning after each injection, run a brief mental check, any unusual stomach pain, any sign of a reaction at the injection site, anything that feels different from the standard nausea. It takes under a minute and means you catch anything worth flagging early. If you are experiencing persistent vomiting or diarrhoea, dehydration becomes a genuine risk; drinking enough fluid is not optional. Our page on managing sickness on Wegovy covers practical strategies in more detail, and if burping is proving disruptive there is specific guidance on sulphur burps too.
Most of what appears above falls under "expect and manage." The following does not. Seek urgent medical attention if you develop:
Severe or persistent stomach pain, particularly if it is intense and spreads to your back, with or without vomiting. This may indicate pancreatitis, which is a serious but uncommon complication. In January 2026, the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a recognised, if infrequent, risk with GLP-1 medicines; the full communication is on the MHRA Drug Safety Updates page. Stop treatment and seek help straight away if this symptom pattern fits.
Symptoms of gallbladder problems, sudden pain in the upper right abdomen, especially after eating, sometimes with nausea or fever. Rapid weight loss of any cause can increase gallstone risk; it is not unique to Wegovy, but worth knowing.
Signs of a serious allergic reaction, swelling of the face, lips or throat, difficulty breathing, a widespread rash. Call 999.
Severe dehydration from prolonged vomiting or diarrhoea, dizziness on standing, very dark urine, inability to keep fluids down. This needs assessment, not waiting it out.
Wegovy's more serious potential side effects are covered in fuller detail on a dedicated page if you want to go deeper. If you are wondering what the main side effects of Wegovy are and how they compare in frequency, that page sets them out clearly alongside how commonly each one occurs. You can also explore the complete Wegovy side-effect profile with notes on how common each one is, and our dedicated page on the side effect of Wegovy walks through each one in plain language to help you know what to expect.
Prescribers are not just there to issue a prescription; they are there to consider whether the benefit-risk balance makes sense for you specifically. That means reviewing your current medicines, your medical history and any conditions that could affect how you tolerate treatment. Wegovy is not suitable for everyone, pregnancy, breastfeeding and actively trying to conceive are situations where it is not recommended, and under-18s are outside the licensed age range.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it is submitted, your answers are not processed by an algorithm. Side effects are part of what the prescriber considers, both at the outset and before each repeat. If something is not working well, the prescriber can adjust the approach. Our clinical team follows the same standard the NHS expects: clinical judgement, not a checkbox. If you have questions before committing, our FAQs cover common concerns, or you can get in touch directly. When you are ready to discuss whether Wegovy suits your situation, check your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.